Opinion
25 February 2026
When Breakthrough Cancer Care Meets India’s Policy Reality
CAR-T therapy highlights the challenge of turning medical innovation into affordable, accessible care
Arpita Mukherjee is an independent immunologist and biochemist specializing in immuno-oncology, CAR-T cell therapy, immune checkpoint biology, and precision immunotherapy.
SDG 3: Good Health and Well-being | SDG 9: Industry, Innovation and Infrastructure
Ministry of Health and Family Welfare MoHFW | Department of Biotechnology DBT | Department of Pharmaceuticals DoPs
Views are personal.
